Pantoprazol Teva (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Teva, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat acid‑related disorders in adults.

GNH USA supplies Pantoprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides batch‑tested product for global distribution.

Pantoprazol Teva, a proton pump inhibitor, is indicated for several acid‑related conditions.

- Gastroesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates mucosal repair and prevents further damage. - Peptic ulcer disease: supports ulcer healing by lowering gastric acidity. - Helicobacter pylori eradication (as part of combination therapy): enhances the effectiveness of antibiotic regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Pantoprazol Teva may cause a range of adverse reactions, which are generally classified by frequency.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Diarrhea: loose stools that usually resolve without intervention. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the upper abdomen. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical treatment. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: extensive skin detachment. - Hepatic enzyme elevation: increased ALT/AST levels. - Acute pancreatitis: abdominal pain with elevated pancreatic enzymes. - Neutropenia or agranulocytosis: marked reduction in white blood cells.

When prescribing Pantoprazol Teva, clinicians should consider several safety measures.

- Assess renal function: adjust use in patients with severe impairment. - Monitor for infection: prolonged acid suppression may increase risk of gastrointestinal infections. - Evaluate need for long‑term therapy: reassess benefits versus risks periodically. - Use caution in hepatic disease: consider liver function monitoring. - Review concomitant medications: check for drugs that may interact with gastric pH changes. - Store at room temperature: keep in the original container, protect from moisture and light.

Pantoprazol Teva can affect the pharmacokinetics of several medicines; interactions vary in clinical significance.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: markedly decreased antiviral exposure, compromising HIV therapy. - HIV protease inhibitors (e.g., ritonavir): reduced plasma concentrations, risking treatment failure. - Methotrexate (high dose): impaired clearance, potentially leading to toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, requiring closer coagulation monitoring. - Digoxin: increased serum levels, necessitating dose adjustment. - Phenytoin: reduced anticonvulsant concentrations, may need therapeutic drug monitoring.